Yokohama City University Medical Center
18
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
5.6%
1 terminated/withdrawn out of 18 trials
91.7%
+5.2% vs industry average
50%
9 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Trimethylamine N-oxide in Myocardial Infarction
Role: lead
the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia
Role: lead
Assessment of Distal Protection Device in Patients at High Risk for Distal Embolism in Acute Coronary Syndrome (ACS)
Role: lead
Endothelial Dysfunction and Plaque Vulnerability
Role: lead
Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran
Role: lead
Kanagawa Combination Anti-hypertensive Therapy (K-CAT)
Role: lead
Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction
Role: lead
Comparison of the Time to Recurrence Between Ranibizumab and Aflibercept
Role: lead
The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris
Role: lead
The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome
Role: lead
Effect of Neutrophil Elastase Inhibitor on Lung Injury After Esophagectomy
Role: lead
Yokohama Assessment of Fluvastatin, Pravastatin, Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Yokohama-ACS)
Role: lead
The Effectiveness of Two Osteoporosis Drugs on Prosthetic Bone Mineral Density (BMD) Loss After Total Hip Arthroplasty(THA)
Role: lead
Differentiation of Aseptic From Septic Loosening by 18F-fluoride PET
Role: lead
Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension
Role: collaborator
Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy
Role: lead
Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease
Role: lead
Effects of Atorvastatin Versus Probucol on Small Dense LDL
Role: lead
All 18 trials loaded